Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TALS
|
Sandeep Chidambar Kulkarni
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 25,316 Added 3.24% |
$199,996
$7.9 p/Share
|
Oct 22
2025 |
|
BWMN
|
Gary Bowman
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 7,500 Reduced 0.0% |
$317,025
$42.27 p/Share
|
Oct 22
2025 |
|
BWMN
|
Gary Bowman
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 1.36% |
$528,375
$42.27 p/Share
|
Oct 22
2025 |
|
TALS
|
Ryan F. Robinson
CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 14,366 Added 50.0% |
$199,974
$13.92 p/Share
|
Oct 22
2025 |
|
PAYX
|
B Thomas Golisano |
SELL
Bona fide gift
|
Direct | 302,050 Reduced 0.82% |
$38,523,457
$127.54 p/Share
|
Oct 22
2025 |
|
SGMO
|
Gregory D Davis
Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct | 6,708 Reduced 3.33% |
$4,427
$0.66 p/Share
|
Oct 22
2025 |
|
SGMO
|
Nikunj Jain
Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 6,708 Reduced 2.65% |
$4,427
$0.66 p/Share
|
Oct 22
2025 |
|
SGMO
|
Prathyusha Duraibabu
PRINCIPAL FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 45,225 Reduced 6.07% |
$29,848
$0.66 p/Share
|
Oct 22
2025 |
|
SGMO
|
Sandy Macrae
PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct | 126,950 Reduced 5.81% |
$83,787
$0.66 p/Share
|
Oct 22
2025 |
|
SGMO
|
Scott B. Willoughby
SVP, CHIEF LEGAL OFFICER, SECY |
SELL
Payment of exercise price or tax liability
|
Direct | 44,122 Reduced 5.9% |
$29,120
$0.66 p/Share
|
Oct 22
2025 |
|
SGMO
|
Nathalie Dubois Stringfellow
SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct | 43,741 Reduced 5.71% |
$28,869
$0.66 p/Share
|
Oct 22
2025 |
|
ABML
|
Scott Jolcover
Chief Mineral Resource Officer |
BUY
Grant, award, or other acquisition
|
Direct | 8,334 Added 2.39% |
-
|
Oct 22
2025 |
|
ABML
|
Ryan Mitchell Melsert
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,834 Added 0.74% |
-
|
Oct 22
2025 |
|
BLFS
|
Roderick De Greef
President and CEO |
SELL
Open market or private sale
|
Direct | 37,795 Reduced 7.16% |
$1,031,803
$27.3 p/Share
|
Oct 22
2025 |
|
MRCY
|
Jean A Bua
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 23.21% |
-
|
Oct 22
2025 |
|
RNA
|
Steven George Hughes
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,209 Added 5.1% |
$22,443
$10.16 p/Share
|
Oct 22
2025 |
|
RNA
|
Steven George Hughes
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,209 Reduced 5.38% |
$105,015
$47.54 p/Share
|
Oct 22
2025 |
|
HGTY
|
Robert I Kauffman
Director |
SELL
Open market or private sale
|
Indirect | 9,495 Reduced 0.0% |
$106,154
$11.18 p/Share
|
Oct 22
2025 |
|
POST
|
Mark W Westphal
PRES., FOODSERVICE |
BUY
Grant, award, or other acquisition
|
Direct | 43,108 Added 17.84% |
-
|
Oct 22
2025 |
|
POST
|
Mark W Westphal
PRES., FOODSERVICE |
SELL
Payment of exercise price or tax liability
|
Direct | 19,658 Reduced 9.9% |
$2,107,141
$107.19 p/Share
|
Oct 22
2025 |
|
POST
|
Jeff A Zadoks
EVP & COO |
BUY
Grant, award, or other acquisition
|
Direct | 48,718 Added 41.82% |
-
|
Oct 22
2025 |
|
POST
|
Jeff A Zadoks
EVP & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 21,461 Reduced 31.67% |
$2,300,404
$107.19 p/Share
|
Oct 22
2025 |
|
POST
|
Matthew J Mainer
EVP, CFO & TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct | 7,308 Reduced 13.53% |
$783,344
$107.19 p/Share
|
Oct 22
2025 |
|
POST
|
Matthew J Mainer
EVP, CFO & TREASURER |
BUY
Grant, award, or other acquisition
|
Direct | 16,588 Added 23.49% |
-
|
Oct 22
2025 |
|
POST
|
Robert V Vitale
PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 62,687 Reduced 6.41% |
$6,719,419
$107.19 p/Share
|
Oct 22
2025 |
|
POST
|
Robert V Vitale
PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct | 142,308 Added 12.71% |
-
|
Oct 22
2025 |
|
CRDO
|
Yat Tung Lam
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 70,000 Reduced 0.0% |
$9,834,300
$140.49 p/Share
|
Oct 22
2025 |
|
POST
|
Nicolas Catoggio
PRES & CEO, PCB |
SELL
Payment of exercise price or tax liability
|
Direct | 18,570 Reduced 23.76% |
$1,990,518
$107.19 p/Share
|
Oct 22
2025 |
|
POST
|
Nicolas Catoggio
PRES & CEO, PCB |
BUY
Grant, award, or other acquisition
|
Direct | 40,723 Added 34.25% |
-
|
Oct 22
2025 |
|
POST
|
Diedre J Gray
EVP, GC & CAO, SECY |
SELL
Payment of exercise price or tax liability
|
Direct | 20,639 Reduced 31.19% |
$2,212,294
$107.19 p/Share
|
Oct 22
2025 |
|
POST
|
Diedre J Gray
EVP, GC & CAO, SECY |
BUY
Grant, award, or other acquisition
|
Direct | 46,852 Added 41.45% |
-
|
Oct 22
2025 |
|
MRCY
|
Debora A Plunkett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 11.3% |
-
|
Oct 22
2025 |
|
MRCY
|
Jana Partners Management, LP
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 2,362 Added 0.0% |
-
|
Oct 22
2025 |
|
CSX
|
Kevin S. Boone
EVP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct | 31,053 Added 11.96% |
$551,811
$17.77 p/Share
|
Oct 22
2025 |
|
CSX
|
Kevin S. Boone
EVP & CCO |
SELL
Open market or private sale
|
Direct | 31,053 Reduced 13.59% |
$1,120,702
$36.09 p/Share
|
Oct 22
2025 |
|
IMVT
|
Jay S Stout
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 2,520 Reduced 1.24% |
$47,955
$19.03 p/Share
|
Oct 22
2025 |
|
IMVT
|
Michael Geffner
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,595 Reduced 1.18% |
$49,382
$19.03 p/Share
|
Oct 22
2025 |
|
VIR
|
Svf Endurance (Cayman) LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 144,266 Reduced 0.0% |
$887,235
$6.15 p/Share
|
Oct 22
2025 |
|
GM
|
Mark L Reuss
President |
BUY
Exercise of conversion of derivative security
|
Direct | 227,570 Added 44.96% |
$8,476,982
$37.25 p/Share
|
Oct 22
2025 |
|
GM
|
Mark L Reuss
President |
SELL
Open market or private sale
|
Direct | 260,600 Reduced 72.67% |
$17,311,658
$66.43 p/Share
|
Oct 22
2025 |
|
WINA
|
Renae M. Gaudette
CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 2,500 Added 11.08% |
$227,475
$90.99 p/Share
|
Oct 22
2025 |
|
BAC
|
Sheri B. Bronstein
Chief People Officer |
SELL
Bona fide gift
|
Direct | 6,000 Reduced 1.81% |
-
|
Oct 22
2025 |
|
MRCY
|
Gerard J Demuro
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 11.9% |
-
|
Oct 22
2025 |
|
MRCY
|
Lisa S Disbrow
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 7.03% |
-
|
Oct 22
2025 |
|
MRCY
|
Orlando D Carvalho
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 3.82% |
-
|
Oct 22
2025 |
|
MRCY
|
Howard L Lance
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 6.85% |
-
|
Oct 22
2025 |
|
MRCY
|
Barry R Nearhos
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,362 Added 7.16% |
-
|
Oct 22
2025 |
|
BSY
|
Gregory S Bentley
Executive Chair & President |
SELL
Payment of exercise price or tax liability
|
Direct | 13,181 Reduced 0.17% |
$685,543
$52.01 p/Share
|
Oct 22
2025 |
|
BSY
|
Gregory S Bentley
Executive Chair & President |
BUY
Grant, award, or other acquisition
|
Direct | 30,135 Added 0.39% |
$1,567,321
$52.01 p/Share
|
Oct 22
2025 |
|
STX
|
James Ci Lee
EVP & CLO |
SELL
Payment of exercise price or tax liability
|
Direct | 540 Reduced 36.14% |
$116,127
$215.05 p/Share
|
Oct 22
2025 |